Article

Paul H. Sartori, MD named new VP at B&L

Bausch & Lomb announced that Paul H. Sartori, PhD, will join the company as corporate vice president and chief human resources officer on March 17.

Rochester, NY-Bausch & Lomb (B&L) announced that Paul H. Sartori, PhD, will join the company as corporate vice president and chief human resources officer on March 17.

Most recently he was senior vice president of organizational development and human resources for Boston-based BioTrove Inc. He has more than two decades of experience in the healthcare, pharmaceutical, and diagnostic industries.

He was a partner and principal at CHM Partners International, LLC, the international executive search and management consulting firm, from 2000 to 2007. Dr. Sartori has also served as executive vice president, External Affairs and Human Resources at Novartis; senior vice president of Human Resources and Communications at CIBA-Geigy; and global vice president of Human Resources at CIBA-Corning Diagnostics. He has held teaching and administrative roles at the University of Virginia and James Madison University.

"I've known Paul for more than 20 years, and have great respect for his business judgment," said Gerald M. Ostrov, B & L chairman and chief executive officer. "He has the ability to develop superior talent, and a sterling reputation for working with organizations to improve their effectiveness. We're fortunate that he's chosen to join Bausch & Lomb as we enter an extended period of growth."

David R. Nachbar, current chief human resources officer for Bausch & Lomb, has decided to leave the company after a transition period. He is considering various options including as-yet unnamed public service opportunities.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.